2023-07-01 2024-06-30 2024-06-30 false 14194990 TWEIDPHARMA LIMITED 2025-09-10 false iso4217:GBP xbrli:pure 14194990 2023-06-30 14194990 2024-06-30 14194990 2023-07-01 2024-06-30 14194990 2022-06-23 14194990 2023-06-30 14194990 2022-06-24 2023-06-30 14194990 bus:SmallEntities 2023-07-01 2024-06-30 14194990 bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 14194990 bus:FullAccounts 2023-07-01 2024-06-30 14194990 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 14194990 core:WithinOneYear 2024-06-30 14194990 core:AfterOneYear 2024-06-30 14194990 core:WithinOneYear 2023-06-30 14194990 core:AfterOneYear 2023-06-30 14194990 core:ShareCapital 2024-06-30 14194990 core:SharePremium 2024-06-30 14194990 core:RevaluationReserve 2024-06-30 14194990 core:OtherReservesSubtotal 2024-06-30 14194990 core:RetainedEarningsAccumulatedLosses 2024-06-30 14194990 core:ShareCapital 2023-06-30 14194990 core:SharePremium 2023-06-30 14194990 core:RevaluationReserve 2023-06-30 14194990 core:OtherReservesSubtotal 2023-06-30 14194990 core:RetainedEarningsAccumulatedLosses 2023-06-30 14194990 core:LandBuildings 2024-06-30 14194990 core:PlantMachinery 2024-06-30 14194990 core:Vehicles 2024-06-30 14194990 core:FurnitureFittings 2024-06-30 14194990 core:OfficeEquipment 2024-06-30 14194990 core:NetGoodwill 2024-06-30 14194990 core:IntangibleAssetsOtherThanGoodwill 2024-06-30 14194990 core:ListedExchangeTraded 2024-06-30 14194990 core:UnlistedNon-exchangeTraded 2024-06-30 14194990 core:LandBuildings 2023-06-30 14194990 core:PlantMachinery 2023-06-30 14194990 core:Vehicles 2023-06-30 14194990 core:FurnitureFittings 2023-06-30 14194990 core:OfficeEquipment 2023-06-30 14194990 core:NetGoodwill 2023-06-30 14194990 core:IntangibleAssetsOtherThanGoodwill 2023-06-30 14194990 core:ListedExchangeTraded 2023-06-30 14194990 core:UnlistedNon-exchangeTraded 2023-06-30 14194990 core:LandBuildings 2023-07-01 2024-06-30 14194990 core:PlantMachinery 2023-07-01 2024-06-30 14194990 core:Vehicles 2023-07-01 2024-06-30 14194990 core:FurnitureFittings 2023-07-01 2024-06-30 14194990 core:OfficeEquipment 2023-07-01 2024-06-30 14194990 core:NetGoodwill 2023-07-01 2024-06-30 14194990 core:IntangibleAssetsOtherThanGoodwill 2023-07-01 2024-06-30 14194990 core:ListedExchangeTraded 2023-07-01 2024-06-30 14194990 core:UnlistedNon-exchangeTraded 2023-07-01 2024-06-30 14194990 core:MoreThanFiveYears 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments 2024-06-30 14194990 core:Non-currentFinancialInstruments 2023-06-30 14194990 dpl:CostSales 2023-07-01 2024-06-30 14194990 dpl:DistributionCosts 2023-07-01 2024-06-30 14194990 core:LandBuildings 2023-07-01 2024-06-30 14194990 core:PlantMachinery 2023-07-01 2024-06-30 14194990 core:Vehicles 2023-07-01 2024-06-30 14194990 core:FurnitureFittings 2023-07-01 2024-06-30 14194990 core:OfficeEquipment 2023-07-01 2024-06-30 14194990 dpl:AdministrativeExpenses 2023-07-01 2024-06-30 14194990 core:NetGoodwill 2023-07-01 2024-06-30 14194990 core:IntangibleAssetsOtherThanGoodwill 2023-07-01 2024-06-30 14194990 dpl:GroupUndertakings 2023-07-01 2024-06-30 14194990 dpl:ParticipatingInterests 2023-07-01 2024-06-30 14194990 dpl:GroupUndertakings core:ListedExchangeTraded 2023-07-01 2024-06-30 14194990 core:ListedExchangeTraded 2023-07-01 2024-06-30 14194990 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-07-01 2024-06-30 14194990 core:UnlistedNon-exchangeTraded 2023-07-01 2024-06-30 14194990 dpl:CostSales 2022-06-24 2023-06-30 14194990 dpl:DistributionCosts 2022-06-24 2023-06-30 14194990 core:LandBuildings 2022-06-24 2023-06-30 14194990 core:PlantMachinery 2022-06-24 2023-06-30 14194990 core:Vehicles 2022-06-24 2023-06-30 14194990 core:FurnitureFittings 2022-06-24 2023-06-30 14194990 core:OfficeEquipment 2022-06-24 2023-06-30 14194990 dpl:AdministrativeExpenses 2022-06-24 2023-06-30 14194990 core:NetGoodwill 2022-06-24 2023-06-30 14194990 core:IntangibleAssetsOtherThanGoodwill 2022-06-24 2023-06-30 14194990 dpl:GroupUndertakings 2022-06-24 2023-06-30 14194990 dpl:ParticipatingInterests 2022-06-24 2023-06-30 14194990 dpl:GroupUndertakings core:ListedExchangeTraded 2022-06-24 2023-06-30 14194990 core:ListedExchangeTraded 2022-06-24 2023-06-30 14194990 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2022-06-24 2023-06-30 14194990 core:UnlistedNon-exchangeTraded 2022-06-24 2023-06-30 14194990 core:NetGoodwill 2024-06-30 14194990 core:IntangibleAssetsOtherThanGoodwill 2024-06-30 14194990 core:LandBuildings 2024-06-30 14194990 core:PlantMachinery 2024-06-30 14194990 core:Vehicles 2024-06-30 14194990 core:FurnitureFittings 2024-06-30 14194990 core:OfficeEquipment 2024-06-30 14194990 core:AfterOneYear 2024-06-30 14194990 core:WithinOneYear 2024-06-30 14194990 core:ListedExchangeTraded 2024-06-30 14194990 core:UnlistedNon-exchangeTraded 2024-06-30 14194990 core:ShareCapital 2024-06-30 14194990 core:SharePremium 2024-06-30 14194990 core:RevaluationReserve 2024-06-30 14194990 core:OtherReservesSubtotal 2024-06-30 14194990 core:RetainedEarningsAccumulatedLosses 2024-06-30 14194990 core:NetGoodwill 2023-06-30 14194990 core:IntangibleAssetsOtherThanGoodwill 2023-06-30 14194990 core:LandBuildings 2023-06-30 14194990 core:PlantMachinery 2023-06-30 14194990 core:Vehicles 2023-06-30 14194990 core:FurnitureFittings 2023-06-30 14194990 core:OfficeEquipment 2023-06-30 14194990 core:AfterOneYear 2023-06-30 14194990 core:WithinOneYear 2023-06-30 14194990 core:ListedExchangeTraded 2023-06-30 14194990 core:UnlistedNon-exchangeTraded 2023-06-30 14194990 core:ShareCapital 2023-06-30 14194990 core:SharePremium 2023-06-30 14194990 core:RevaluationReserve 2023-06-30 14194990 core:OtherReservesSubtotal 2023-06-30 14194990 core:RetainedEarningsAccumulatedLosses 2023-06-30 14194990 core:NetGoodwill 2022-06-23 14194990 core:IntangibleAssetsOtherThanGoodwill 2022-06-23 14194990 core:LandBuildings 2022-06-23 14194990 core:PlantMachinery 2022-06-23 14194990 core:Vehicles 2022-06-23 14194990 core:FurnitureFittings 2022-06-23 14194990 core:OfficeEquipment 2022-06-23 14194990 core:AfterOneYear 2022-06-23 14194990 core:WithinOneYear 2022-06-23 14194990 core:ListedExchangeTraded 2022-06-23 14194990 core:UnlistedNon-exchangeTraded 2022-06-23 14194990 core:ShareCapital 2022-06-23 14194990 core:SharePremium 2022-06-23 14194990 core:RevaluationReserve 2022-06-23 14194990 core:OtherReservesSubtotal 2022-06-23 14194990 core:RetainedEarningsAccumulatedLosses 2022-06-23 14194990 core:AfterOneYear 2023-07-01 2024-06-30 14194990 core:WithinOneYear 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:CostValuation 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2023-07-01 2024-06-30 14194990 core:Non-currentFinancialInstruments core:CostValuation 2024-06-30 14194990 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-06-30 14194990 core:Non-currentFinancialInstruments core:CostValuation 2023-06-30 14194990 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2023-06-30 14194990 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2023-06-30 14194990 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2023-06-30 14194990 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2023-06-30 14194990 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2023-06-30 14194990 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2023-06-30 14194990 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2023-06-30 14194990 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2023-06-30 14194990 bus:Director1 2023-07-01 2024-06-30 14194990 bus:Director2 2023-07-01 2024-06-30 14194990 bus:Director3 2023-07-01 2024-06-30

TWEIDPHARMA LIMITED

Registered Number
14194990
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

TWEIDPHARMA LIMITED
Company Information
for the year from 1 July 2023 to 30 June 2024

Directors | DUNCALF, Ian James
| FERGUS, Darren
| TWEEDIE, Oliver John

Registered Address | Stevenage Bioscience Catalyst
| Gunnels Wood Road
| Stevenage
| SG1 2FX

Registered Number | 14194990 (England and Wales)

TWEIDPHARMA LIMITED
Balance Sheet as at
30 June 2024

| Notes | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |
Debtors |  | 2,464 |  |  |  | 8,272 |  |
Cash at bank and on hand |  | 2,614 |  |  |  | 644 |  |
|  | 5,078 |  |  |  | 8,916 |  |
Creditors amounts falling due within one year | 3 | (13,437) |  |  |  | (6,070) |  |
Net current assets (liabilities) |  |  |  | (8,359) |  |  |  | 2,846
Total assets less current liabilities |  |  |  | (8,359) |  |  |  | 2,846
Net assets |  |  |  | (8,359) |  |  |  | 2,846
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 10,000 |  |  |  | 10,000
Profit and loss account |  |  |  | (18,359) |  |  |  | (7,154)
Shareholders' funds |  |  |  | (8,359) |  |  |  | 2,846

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 10 September 2025, and are signed on its behalf by:
FERGUS, Darren Director Registered Company No. 14194990

TWEIDPHARMA LIMITED
Notes to the Financial Statements
for the year ended 30 June 2024

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

2. | Average number of employees
--- | ---

|  | 2024 |  | 2023
| Average number of employees during the year | 3 |  | 3

3. | Creditors: amounts due within one year
--- | ---

|  | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 4,106 |  | -
| Other creditors | 8,671 |  | 5,470
| Accrued liabilities and deferred income | 660 |  | 600
| Total | 13,437 |  | 6,070